- Home
- CBFV vs NKTX Comparison
CBFV vs NKTX Comparison
Compare CBFV & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- NKTX
- Stock Information
- Founded
- CBFV 1901
- NKTX 2015
- Country
- CBFV United States
- NKTX United States
- Employees
- CBFV N/A
- NKTX N/A
- Industry
- CBFV Major Banks
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CBFV Finance
- NKTX Health Care
- Exchange
- CBFV Nasdaq
- NKTX Nasdaq
- Market Cap
- CBFV 174.9M
- NKTX 147.7M
- IPO Year
- CBFV N/A
- NKTX 2020
- Fundamental
- Price
- CBFV $34.49
- NKTX $1.83
- Analyst Decision
- CBFV Buy
- NKTX Strong Buy
- Analyst Count
- CBFV 2
- NKTX 5
- Target Price
- CBFV $36.00
- NKTX $13.25
- AVG Volume (30 Days)
- CBFV 5.7K
- NKTX 702.8K
- Earning Date
- CBFV 10-23-2025
- NKTX 11-10-2025
- Dividend Yield
- CBFV 2.98%
- NKTX N/A
- EPS Growth
- CBFV N/A
- NKTX N/A
- EPS
- CBFV 0.51
- NKTX N/A
- Revenue
- CBFV $39,329,000.00
- NKTX N/A
- Revenue This Year
- CBFV $10.71
- NKTX N/A
- Revenue Next Year
- CBFV $12.52
- NKTX N/A
- P/E Ratio
- CBFV $68.57
- NKTX N/A
- Revenue Growth
- CBFV N/A
- NKTX N/A
- 52 Week Low
- CBFV $26.01
- NKTX $1.31
- 52 Week High
- CBFV $35.37
- NKTX $3.16
- Technical
- Relative Strength Index (RSI)
- CBFV 66.85
- NKTX 40.43
- Support Level
- CBFV $32.70
- NKTX $1.77
- Resistance Level
- CBFV $35.37
- NKTX $1.83
- Average True Range (ATR)
- CBFV 0.75
- NKTX 0.09
- MACD
- CBFV 0.20
- NKTX -0.00
- Stochastic Oscillator
- CBFV 91.98
- NKTX 37.14
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.